CNXC, US20602D1019

Concentrix stock rebounds 10.5 percent after guidance cut

Published on 09/22/2026 at 05:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Concentrix stock traded at USD 27.87 on September 21, 2026, after a 1.7 percent decline. Q2 revenue rose 1.9 percent, while EPS fell 2.6 percent year over year.

CNXC, US20602D1019, Illustration mit AI erstellt.

Concentrix Corporation (ISIN US20602D1019) closed at USD 27.87 on September 21, 2026, after falling 1.7 percent in the latest completed Nasdaq session. The stock was nevertheless up 10.5 percent from the level reported after the second-quarter results, leaving the revised fiscal-year outlook as the central issue for investors.

Revenue grows but EPS falls

According to ScanX on September 21, 2026, Concentrix generated USD 2.4625 billion in fiscal second-quarter revenue, up 1.9 percent from USD 2.4174 billion in the prior-year quarter. Non-GAAP diluted EPS was USD 2.63, down 2.6 percent from USD 2.70 in fiscal second-quarter 2025.

The quarterly comparison is mixed rather than uniformly negative. Adjusted EBITDA reached USD 347.4 million in Q2 fiscal 2026, representing a 14.1 percent margin, while revenue growth on a constant-currency basis was only 0.6 percent. The narrow revenue increase therefore came with weaker earnings per share and slower underlying growth.

Guidance points to slower growth

ScanX reported on September 21, 2026, that Concentrix reduced fiscal 2026 adjusted EPS guidance to USD 10.83 to USD 11.18, below the cited analyst estimate of USD 11.97. The company also lowered its revenue outlook to USD 9.93 billion to USD 10.03 billion, compared with the cited estimate of USD 10.14 billion.

The outlook makes the next quarter important. Management expects fiscal third-quarter revenue between USD 2.465 billion and USD 2.490 billion, with non-GAAP diluted EPS between USD 2.65 and USD 2.77. The company also expects fiscal-year adjusted free cash flow of approximately USD 630 million to USD 650 million, giving cash generation a clearer role in the valuation debate.

Analysts cut targets before results

According to ScanX on September 21, 2026, Concentrix shares closed at USD 27.87 while trading below the consensus price targets cited for Barrington Research and Baird. The preview identified analyst target reductions as part of the market backdrop ahead of the fiscal third-quarter report.

The key comparison is between the share price response and the earnings outlook: the stock had recovered 10.5 percent since the results, but fiscal 2026 revenue guidance remained below the cited USD 10.14 billion estimate. That gap keeps operating growth and margin delivery more important than the short-term rebound.

Stock closes at USD 27.87

Concentrix stock closed at USD 27.87 on Nasdaq on September 21, 2026, down 1.7 percent from the prior close. The same market snapshot cited a market capitalization of USD 1.701 billion.